###begin article-title 0
Patterns of evolution of host proteins involved in retroviral pathogenesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 231 239 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G</italic>
###xml 255 261 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19</italic>
###xml 262 265 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 321 325 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
Evolutionary analysis may serve as a useful approach to identify and characterize host defense and viral proteins involved in genetic conflicts. We analyzed patterns of coding sequence evolution of genes with known (TRIM5alpha and APOBEC3G) or suspected (TRIM19/PML) roles in virus restriction, or in viral pathogenesis (PPIA, encoding Cyclophilin A), in the same set of human and non-human primate species.
###end p 3
###begin title 4
Results and conclusion
###end title 4
###begin p 5
###xml 88 97 88 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 214 219 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 401 412 397 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19/PML </italic>
###xml 338 341 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
This analysis revealed previously unidentified clusters of positively selected sites in APOBEC3G and TRIM5alpha that may delineate new virus-interaction domains. In contrast, our evolutionary analyses suggest that PPIA is not under diversifying selection in primates, consistent with the interaction of Cyclophilin A being limited to the HIV-1M/SIVcpz lineage. The strong sequence conservation of the TRIM19/PML sequences among primates suggests that this gene does not play a role in antiretroviral defense.
###end p 5
###begin title 6
Background
###end title 6
###begin p 7
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 495 496 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 497 498 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 505 513 501 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G</italic>
###xml 588 589 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 590 591 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 848 853 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 860 861 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 954 963 946 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 964 965 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Evolutionary genomics approaches have been proposed as powerful tools to identify protein regions relevant for host-pathogen interactions [1]. Identifying signatures of genetic conflict can open the way to biological testing of hypotheses regarding the function of host proteins. In retrovirology, the utility of this approach was recently demonstrated in evolutionary analyses of the antiretroviral defense genes TRIM5alpha, encoding a retrovirus restriction factor targeting the viral capsid [2,3], and APOBEC3G, coding for a cytidine deaminase that hypermutates viral DNA in primates [4-6]. Both genes were shown to have been shaped by positive selection, which led to the rapid fixation of adaptive amino acid replacement substitutions. The two genes revealed two different patterns of positive selection: a localized region of rapid change in TRIM5alpha [3], and a pattern where positively selected residues are scattered throughout the sequence in APOBEC3G [5].
###end p 7
###begin p 8
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 266 275 262 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 348 349 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 416 417 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 418 419 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 454 459 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 581 583 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 670 674 666 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CPZ </sub>
###xml 727 729 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 519 524 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 660 663 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To assess the potential of an evolutionary approach to identify further primate genes/proteins involved in virus defense, we analyzed coding sequence evolution of two additional genes, TRIM19 (PML) and PPIA, and reassessed the selective signatures of TRIM5alpha and APOBEC3G in a common set of primates, representing 40 million years of evolution [7]. TRIM19 (PML) was proposed to possess anti(retro)viral activity [8,9], while Cyclophilin A, encoded by PPIA (peptidyl-prolyl cis-trans isomerase), is incorporated into HIV-1 particles through an interaction with the viral capsid [10]. Cyclophilin A is incorporated only into viral particles of viruses of the HIV-1M/SIVCPZ lineage, where it is required for viral replication [11].
###end p 8
###begin p 9
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
To trace the evolutionary history of these genes, we first sequenced their coding regions from eleven primate species [see Additional files 1 and 2]. We then analyzed their substitutional patterns in the framework of the accepted primate phylogeny [7] using several codon-based maximum likelihood procedures as implemented in the codeml tool of the PAML program package [12] (Figure 1).
###end p 9
###begin p 10
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Phylogenetic trees of candidate antiviral defense genes</bold>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></sub>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>S </italic></sub>
Phylogenetic trees of candidate antiviral defense genes. KA/KS values and the estimated number of nonsynonymous and synonymous substitutions (in parentheses) for each branch are indicated. Approximate divergence times in millions of years (mya) are shown [7].
###end p 10
###begin p 11
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 332 333 332 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 335 337 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 392 401 388 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 416 417 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 417 418 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 419 420 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 420 422 416 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 559 561 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 577 582 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 586 593 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
###xml 608 609 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 609 610 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 611 612 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 612 614 608 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 788 789 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
To obtain an overview of the coding sequence evolution, we estimated the number of nonsynonymous (KA) over synonymous (KS) substitutions per site (averaged over the entire sequence) for each branch of the trees using the free-ratio model of codeml [12]. Similarly to previous reports [3,5,6], this analysis revealed generally high KA/KS values on the different branches of the TRIM5alpha and APOBEC3G trees (average KA/KS ~1.1 for both genes), indicating that these genes show accelerated amino acid replacement rates due to the action of positive selection [13]. In contrast, PPIA and TRIM19 (PML) show low KA/KS values (0.05 and 0.15, respectively, when averaged over the entire tree), suggesting that their protein sequences have been strongly preserved by purifying selection (Figure 1).
###end p 11
###begin p 12
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 80 82 80 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 447 449 447 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 578 580 578 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-30</sup>
###xml 597 602 597 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 612 621 608 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 697 704 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
###xml 708 713 704 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 720 721 716 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 728 729 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 729 730 725 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 731 732 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 732 734 728 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 790 795 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 802 803 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 803 804 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 805 806 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 806 808 798 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 818 827 810 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 828 829 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 829 830 821 822 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 831 832 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 832 834 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 988 993 980 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 1003 1012 991 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 1084 1091 1072 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
###xml 1095 1100 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 1168 1169 1156 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
In more detailed analyses, we then utilized models that allow for different KA/KS rates at different sites of the sequences, because adaptive evolution often occurs at a limited number of sites [14]. We first compared a null model ("M1a", [15,16]), which assumes two site classes (sites under purifying selection and neutrally evolving sites), to an alternative model ("M2a", [15,16]), which adds a third site class that allows for sites with KA/KS > 1, using likelihood ratio tests [17]. This comparison revealed that the alternative model provides a significantly better fit (P < 10-30) for the TRIM5alpha and APOBEC3G genes than the null model, whereas the null model could not be rejected for TRIM19 and PPIA (Table 1). The KA/KS for the additional site class is larger than 1 for both TRIM5alpha (KA/KS ~6.4) and APOBEC3G (KA/KS ~4.4), strongly suggesting adaptive protein evolution driven by positive selection at a subset of sites. Thus, this analysis supports the hypothesis that TRIM5alpha and APOBEC3G evolved under positive selection. Contrary to this, nearly all sites of TRIM19 and PPIA (91.5% and 100%, respectively) are under purifying selection (Table 1).
###end p 12
###begin p 13
Codeml analyses using site-specific models.
###end p 13
###begin p 14
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a the likelihood models used are described in the text
###end p 14
###begin p 15
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b class of sites under purifying selection
###end p 15
###begin p 16
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c class of sites evolving neutrally
###end p 16
###begin p 17
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">A</sub>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
d class of sites that may show KA/KS > 1
###end p 17
###begin p 18
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e </sup>
e sites pinpointed to be under positive selection by Bayes Empirical Bayes analysis
###end p 18
###begin p 19
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f </sup>
f test not applicable (M1a and M2a not significantly different)
###end p 19
###begin p 20
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 121 130 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 150 155 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 254 256 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 271 273 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 429 431 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 501 502 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 621 623 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 624 626 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 770 772 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 889 894 877 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L117H</sub>
###xml 904 906 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 907 909 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 795 800 <span type="species:ncbi:9606">human</span>
###xml 816 829 <span type="species:ncbi:9544">Rhesus monkey</span>
###xml 873 878 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Using a recently developed Bayesian approach [16], we analyzed the site class under positive selection in TRIM5alpha and APOBEC3G in more detail. For TRIM5alpha, 11 of 493 (2%) codon sites can be predicted to be positively selected with high confidence (P > 0.95, Figure 2A). Two clusters of positive selection are found in the SPRY domain. The first cluster resides between amino acids 322 to 340 in the variable region 1 (v1, [18]), a region previously described as a "patch" of positive selection [3]. Replacement of the v1 region, or of specific amino acids within v1, modifies the restriction pattern of TRIM5alpha [19,20]. The second cluster, localized between amino acids 381 to 389, corresponds to the previously described variable region v2 of the SPRY domain [18]. Substitution of the human v2 region by a Rhesus monkey v2 exhibits no inhibitory activity against HIV-1 or a N-MLVL117H chimera [19,20]. However, the role of v2 in species-specific lentiviral restriction has not yet been extensively tested.
###end p 20
###begin p 21
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM5</italic>
###xml 50 58 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G</italic>
###xml 0 58 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Codons under positive selection in <italic>TRIM5</italic>&#945; and <italic>APOBEC3G</italic></bold>
###xml 177 184 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
Codons under positive selection in TRIM5alpha and APOBEC3G. Y-axis: Probabilities of positively selected codons (see text). X-axis: amino acid numbering and functional domains. TRIM19 is shown for comparison.
###end p 21
###begin p 22
###xml 94 103 94 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOBEC3G </italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 924 926 924 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 291 298 <span type="species:ncbi:9581">gibbons</span>
###xml 303 311 <span type="species:ncbi:9590">siamangs</span>
###xml 795 800 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The analysis also predicts a large number (24 of 384, 6%) of positively selected sites in the APOBEC3G (Figure 2B) sequence. This result is consistent with previous reports by Sawyer et al. [5]. However, the inclusion of several new species from an additional hominoid lineage, Hylobatidae (gibbons and siamangs), points to the existence of a cluster of residues under positive selection between amino acids 62 and 103, the region that defines the Vif-interaction domain [21]. The protein Vif, which counteracts the activity of APOBEC3G, is encoded by nearly all lentiviruses [22]. Within the Vif-interaction domain of APOBEC3G, 10 residues can be pinpointed to have evolved under strong positive selection. Interestingly, the APOBEC3G amino acid position 128, which controls the ability of the HIV-1 Vif protein to bind and inactivate this host defense factor [23,24], is correctly identified as being positively selected (P > 0.987).
###end p 22
###begin p 23
###xml 338 339 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 803 805 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 806 808 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 933 950 929 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">Additional file 3</xref>
###xml 780 785 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The parallel assessment of multiple genes in the same set of primates allows for several considerations and conclusions. First, by including additional primate lineages, we modify and complement previously observed patterns for two antiviral defense genes/proteins. For TRIM5alpha, our analysis confirms previous results by Sawyer et al [3], but underscores the potential interest of the second variable region of the SPRY domain that may be of functional relevance and merits further experimental analysis. With respect to APOBEC3G, our analysis extends previous reports that showed protein-wide distribution of positively selected residues. It suggests that this protein potentially carries a functionally relevant cluster of selected residues that coincides with the region of HIV-1-Vif interaction [23,24]. Positive selected sites by Bayes Empirical Bayes Inference with probabilities P > 0.95 for the two proteins are listed in Additional file 3.
###end p 23
###begin p 24
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM19 </italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PML</italic>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 489 490 489 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 874 875 874 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 573 599 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 604 621 <span type="species:ncbi:11320">influenza A virus</span>
###xml 631 642 <span type="species:ncbi:11620">Lassa virus</span>
###xml 647 681 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
Second, the failure to identify signatures of positive selection in the TRIM19 (PML) gene suggests that its encoded protein does not have antiviral activity, or that the protein acts as an intermediary, lacking a physical protein-protein interaction with the pathogen. TRIM19 (PML) has been implicated in many functions, for example, in apoptosis and cell proliferation [9]. In addition, TRIM19 (PML) expression may act as an effector of the antiviral state induced by type I interferons [9]. Overexpression of TRIM19 (PML) is reported to confer resistance to infection by vesicular stomatitis virus and influenza A virus. Rabies, Lassa virus and lymphocytic choriomeningitis virus replicate to higher levels in PML-negative cells, whereas overexpression of the protein has no significant effect. Various roles have been proposed for TRIM19 (PML) in retroviral replication [8,25], although these findings remain controversial [26]. Many other viruses, including herpes simplex type 1 disturb the nuclear bodies that contain, among other proteins, TRIM19 (PML). However, it is unclear whether these effects are a consequence of the viral infection or a sign of its participation in antiviral defense. Thus, the effect of TRIM19 (PML) might be indirect. Failure to identify a signature of positive selection militates against a direct role of this protein in antiviral defense, because it would be expected that a prolonged contact with multiple pathogens over long evolutionary time periods would have resulted in signatures of positive selection indicative of a genetic conflict.
###end p 24
###begin p 25
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 366 370 366 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink">CPZ </sub>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPIA </italic>
###xml 226 231 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 272 277 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 356 359 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 460 471 <span type="species:ncbi:9505">Owl monkeys</span>
###xml 506 511 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 852 855 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Finally, the absence of a signature of positive Darwinian selection in Cyclophilin A provides a complement to the understanding of the role of this protein in retroviral pathogenesis. Cyclophilin A interacts directly with the HIV-1 capsid, an interaction that may protect HIV-1 from antiviral restriction activity [27]. Although required by members of the HIV-1M/SIVCPZ lineage for replication, it is not needed by other primate immunodeficiency viruses [11]. Owl monkeys exhibit post-entry restriction of HIV-1 mediated by a TRIM5-Cyclophilin A fusion protein generated by retroposition [28]. Evolutionary analysis of PPIA indicates that Cyclophilin A has been preserved by strong purifying selection, leaving its protein sequence virtually unchanged. This is consistent with the interaction of Cyclophilin A and the viral capsid being limited to the HIV-1M/SIVcpz lineage.
###end p 25
###begin p 26
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Together, the results presented here further support that an evolutionary genomics approach may be very useful for systematically assessing functional roles of primate host proteins potentially relevant in viral pathogenesis [29]. Candidates for this approach may include other members of the TRIM or APOBEC families [30,31] as well as proteins involved in pathogen recognition and life cycle. Signatures of positive selection, but also the absence of signs of a genetic conflict, constitute relevant information for understanding the nature of virus-host protein interactions.
###end p 26
###begin title 27
Competing interests
###end title 27
###begin p 28
The author(s) declare that they have no competing interests.
###end p 28
###begin title 29
Authors' contributions
###end title 29
###begin p 30
MO carried out the molecular genetic studies, performed sequence and phylogenetic analysis and contributed to drafting of the manuscript. GB and RM carried out molecular genetic studies. HK conceived the study, performed the evolutionary genomic analyses and drafted the manuscript. AT conceived the study, supervised the molecular genetic analysis, assured funding, and drafted the manuscript.
###end p 30
###begin title 31
Supplementary Material
###end title 31
###begin title 32
Additional file 1
###end title 32
###begin p 33
GenBank accession numbers.
###end p 33
###begin p 34
Click here for file
###end p 34
###begin title 35
Additional file 2
###end title 35
###begin p 36
Primers for amplification and sequence analysis.
###end p 36
###begin p 37
Click here for file
###end p 37
###begin title 38
Additional file 3
###end title 38
###begin p 39
Positive selected sites by Bayes Empirical Bayes Inference with probabilities P > 0.95.
###end p 39
###begin p 40
Click here for file
###end p 40
###begin title 41
Acknowledgements
###end title 41
###begin p 42
Supported by Swiss National Science Foundation grant no. 310000-110012/1 (to A.T.) and 3100A0-104181 (to H.K.), research awards of the Cloetta and Leenaards Foundations (to A.T.), and a grant for interdisciplinary research from the Faculty of Biology and Medicine of the University of Lausanne (to A.T. and H.K.).
###end p 42
###begin article-title 43
The power of phylogenetic comparison in revealing protein function
###end article-title 43
###begin article-title 44
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys
###end article-title 44
###begin article-title 45
Positive selection of primate TRIM5{alpha} identifies a critical species-specific retroviral restriction domain
###end article-title 45
###begin article-title 46
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
###end article-title 46
###begin article-title 47
Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G
###end article-title 47
###begin article-title 48
Rapid evolution of primate antiviral enzyme APOBEC3G
###end article-title 48
###begin article-title 49
The genomic record of Humankind's evolutionary roots
###end article-title 49
###begin article-title 50
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication
###end article-title 50
###begin article-title 51
TRIM family proteins: retroviral restriction and antiviral defence
###end article-title 51
###begin article-title 52
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction
###end article-title 52
###begin article-title 53
###xml 57 92 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 105 138 <span type="species:ncbi:11723">simian immunodeficiency virus SIV</span>
###xml 163 168 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses
###end article-title 53
###begin article-title 54
PAML: a program package for phylogenetic analysis by maximum likelihood
###end article-title 54
###begin article-title 55
Statistical methods for detecting molecular adaptation
###end article-title 55
###begin article-title 56
Codon-substitution models for heterogeneous selection pressure at amino acid sites
###end article-title 56
###begin article-title 57
Bayes empirical bayes inference of amino acid sites under positive selection
###end article-title 57
###begin article-title 58
Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution
###end article-title 58
###begin article-title 59
The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates
###end article-title 59
###begin article-title 60
###xml 95 100 <span type="species:ncbi:9606">Human</span>
Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5{alpha} Determines the Potency of Human Immunodeficiency Virus Restriction
###end article-title 60
###begin article-title 61
###xml 49 54 <span type="species:ncbi:9606">Human</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Single Amino Acid Change in the SPRY Domain of Human Trim5alpha Leads to HIV-1 Restriction
###end article-title 61
###begin article-title 62
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
###end article-title 62
###begin article-title 63
###xml 25 54 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Further investigation of simian immunodeficiency virus Vif function in human cells
###end article-title 63
###begin article-title 64
A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif)
###end article-title 64
###begin article-title 65
A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action
###end article-title 65
###begin article-title 66
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator
###end article-title 66
###begin article-title 67
As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity
###end article-title 67
###begin article-title 68
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific incorporation of cyclophilin A into HIV-1 virions
###end article-title 68
###begin article-title 69
###xml 53 63 <span type="species:ncbi:9505">owl monkey</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
###end article-title 69
###begin article-title 70
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Adaptation, co-evolution, and human susceptibility to HIV-1 infection
###end article-title 70
###begin article-title 71
The tripartite motif family identifies cell compartments
###end article-title 71
###begin article-title 72
###xml 79 84 <span type="species:ncbi:9606">human</span>
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
###end article-title 72

